Connect Biopharma Holdings Limited(NASDAQ:CNTB) 
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antib...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.60
H 0.63
L 0.51
C 0.63
V 226,750
10EMA 0.63
20EMA 0.63
60EMA 0.63
120EMA 0.63
250EMA 0.63